Hjem › Aterosklerose › Tennessee
Kliniske studier for Aterosklerose i Tennessee
9 studier for Aterosklerose søker deltakere på steder i Tennessee.
Byer i Tennessee
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Vanderbilt University School of Medicine (VUSM) - Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Nashville
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- WR-Clinsearch, LLC, Chattanooga
- Erlanger Health System, Chattanooga
- The Jackson Clinic, Jackson
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07157774Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
- St. Jude Children's Research Hospital, Memphis
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07594392Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Stern Cardiovascular Foundation Inc, Germantown
- Accellacare of Knoxville, Knoxville
- Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell
- og 1 flere
RekruttererFase 3
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- og 2 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Chattanooga
- Research Site, Chattanooga
- Research Site, Greeneville
- og 9 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Novartis Investigative Site, Tullahoma
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Apex Cardiology Research Associates of Jackson, Jackson
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Memphis VA Medical Center, Memphis, TN, Memphis
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT02915198Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.